Coronary revascularization for patients with unprotected left main coronary artery disease: evidence, guidelines, and

Issam D Moussa1, S Chiu Wong, Ted Feldman

  • 1Department of Medicine, Division of Cardiology, Weill Medical College of Cornell University, New York, New York 10021, USA. ism9003@med.cornell.edu

Insights

Current guidelines favor coronary artery bypass graft (CABG) surgery over percutaneous coronary interventions (PCI) for unprotected left main coronary artery disease (ULMCAD). This review examines the weak evidence and advocates for patient-centered decision-making.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Current guidelines recommend coronary artery bypass graft (CABG) surgery (Class IA) for unprotected left main coronary artery disease (ULMCAD) revascularization.
  • Percutaneous coronary interventions (PCI) for ULMCAD are currently a Class III recommendation.
  • The evidence supporting these guideline recommendations is considered weak and outdated.

Purpose of the Study:

  • To critically reevaluate the current state-of-the-art in revascularization for patients with ULMCAD who are suitable surgical candidates.
  • To highlight the discrepancy between existing practice guidelines and patient-centered clinical decision-making.
  • To appraise the evidence base for current guidelines and review emerging data comparing CABG and PCI for ULMCAD.

Main Methods:

  • Literature review and critical appraisal of existing evidence.
  • Analysis of current clinical practice guidelines for ULMCAD.
  • Evaluation of contemporary data on CABG versus PCI for ULMCAD.

Main Results:

  • Guideline recommendations for ULMCAD treatment are based on weak and outdated evidence.
  • A divergence exists between guideline-based practice and patient-centered decision-making.
  • Emerging data may challenge the current preferential recommendation for CABG over PCI in select ULMCAD patients.

Conclusions:

  • The current evidence supporting guideline recommendations for ULMCAD revascularization is insufficient.
  • A contemporary approach to ULMCAD treatment requires critical appraisal of evidence and patient-specific factors.
  • Decision-making for ULMCAD should integrate current knowledge and prioritize patient-centered care over rigid guideline adherence.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...